Search research articles
Contact Us
Filters
Showing results (81-90 of 140) with videos related to
Page
of 14
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
May 31, 2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Paul K Paik, Charles M Rudin, Maria C Pietanza, et al.
Cancer
|
May 11, 2016
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)
Chandra P Belani, Suzanne E Dahlberg, Charles M Rudin, et al.
Oncotarget
|
February 23, 2018
Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer
Teruo Yamauchi, Jose Rodrigo Espinosa Fernandez, Chiyo K Imamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease
Kristin Baird, Leora E Comis, Galen O Joe, et al.
World Journal of Oncology
|
January 21, 2022
Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases
Hiroto Nakano, Takuto Miyamoto, Yelena Y Janjigian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use
Apurva K Srivastava, Soumya Jaganathan, Laurie Stephen, et al.
Cancer
|
November 14, 2015
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
Anne M Noonan, Kristen P Bunch, Jin-Qiu Chen, et al.
Cancers
|
June 2, 2021
Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXA
Carter K Fairchild, Konstantinos V Floros, Sheeba Jacob, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers
Jibran Ahmed, Geraldine O'Sullivan Coyne, Larry V Rubinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
James Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 140) with videos related to
Sort By:
Page
of 14
Lung Cancer (Amsterdam, Netherlands)
|
May 31, 2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Paul K Paik, Charles M Rudin, Maria C Pietanza, et al.
Cancer
|
May 11, 2016
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)
Chandra P Belani, Suzanne E Dahlberg, Charles M Rudin, et al.
Oncotarget
|
February 23, 2018
Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer
Teruo Yamauchi, Jose Rodrigo Espinosa Fernandez, Chiyo K Imamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease
Kristin Baird, Leora E Comis, Galen O Joe, et al.
World Journal of Oncology
|
January 21, 2022
Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases
Hiroto Nakano, Takuto Miyamoto, Yelena Y Janjigian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use
Apurva K Srivastava, Soumya Jaganathan, Laurie Stephen, et al.
Cancer
|
November 14, 2015
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
Anne M Noonan, Kristen P Bunch, Jin-Qiu Chen, et al.
Cancers
|
June 2, 2021
Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXA
Carter K Fairchild, Konstantinos V Floros, Sheeba Jacob, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers
Jibran Ahmed, Geraldine O'Sullivan Coyne, Larry V Rubinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
James Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Page
of 14